CF PharmTech Competitors and Similar CompaniesClear all
CF PharmTech's competitors and similar companies include HiFiBiO Therapeutics, CMG Pharmaceutical, ThermoGenesis and Respivant Sciences.
 CF PharmTech CF PharmTech (长风药业股份有限公司) is a specialty pharmaceutical company focused on the development and manufacturing of inhalation products. |  HiFiBiO Therapeutics HiFiBiO Therapeutics is a developer of biotherapeutics with a single-cell analytics platform for extensive immune profiling. |  CMG Pharmaceutical CMG Pharmaceutical is a company that specializes in the oral thin film (OTF) technology. |  ThermoGenesis ThermoGenesis Holdings (formerly known as Cesca Therapeutics) is a regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics. |  Respivant Sciences Respivant Sciences is a clinical-stage biopharmaceutical company that aims to help patients suffering from respiratory diseases. | |
Founding Date | Founding Date 2007 | Founding Date 2013 | Founding Date 2001 | Founding Date 1986 | Founding Date 2018 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Suzhou Shi, CN HQ Nanjing Shi, CN Wuxi Shi, CN City Of Industry, US | Locations Paris, FR HQ Shanghai, CN Cambridge, US | Locations Seongnam-si, KR HQ | Locations Rancho Cordova, US HQ Wuxi Shi, CN | Locations San Diego, US HQ |
Employees | Employees 294% increase | Employees 635% decrease | Employees 273 | Employees 5338% decrease | Employees 2 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₩105.2b (FY, 2025) | Revenue (est.) $9.4m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ₩43.4b (FY, 2025) | Cost of goods $7.5m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ₩61.8b (FY, 2025) | Gross profit $1.9m (FY, 2023) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income (₩10.1b) (FY, 2025) | Net income ($18.9m) (FY, 2023) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 50m (almost 6 years ago) | Latest funding round $ 75m (almost 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 205.4m | Total funding raised $ 179.5m | Total funding raised N/A | Total funding raised $ 15m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
HiFiBiO Therapeutics
HQ
Paris, FR
Employees
63↓ 5% decrease
HiFiBiO Therapeutics is a developer of biotherapeutics with a single-cell analytics platform for extensive immune profiling.
View companyCMG Pharmaceutical
HQ
Seongnam-si, KR
Employees
273
CMG Pharmaceutical is a company that specializes in the oral thin film (OTF) technology.
View companyThermoGenesis
HQ
Rancho Cordova, US
Employees
53↓ 38% decrease
ThermoGenesis Holdings (formerly known as Cesca Therapeutics) is a regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics.
View companyRespivant Sciences
HQ
San Diego, US
Employees
2
Respivant Sciences is a clinical-stage biopharmaceutical company that aims to help patients suffering from respiratory diseases.
View company